Compound details
Butyric acid
| Compound ID | CDAMM00569 |
|---|---|
| Common name | Butyric acid | IUPAC name | butanoic acid |
| Molecular formula | C4H8O2 |
| Retention time | 8.87 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 127.015 | Theoretical mz | 127.016 |
| Error | 5.97 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.2489 |
| Inchi key | FERIUCNNQQJTOY-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(O)CCC |
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P24046 | GABRR1 | GABA receptor rho-1 subunit | T99665 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| P48066 | SLC6A11 | GABA transporter 3 | T38200 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SwissTargetPrediction |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SEA |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| O75164 | KDM4A | Lysine-specific demethylase 4A | T18904 | SEA |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SEA |
| P15090 | FABP4 | Fatty acid binding protein adipocyte | T07217 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SEA |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SEA |
| Q9Y2K7 | KDM2A | Lysine-specific demethylase 2A | T71949 | SEA |
| Q8TDS5 | OXER1 | Oxoeicosanoid receptor 1 | T68834 | SEA |
| Q6ZMT4 | KDM7A | Lysine-specific demethylase 7A/7B | T18784 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| Q92820 | GGH | Gamma-glutamyl hydrolase | T71646 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| Q9UPP1 | PHF8 | Histone lysine demethylase PHF8 | T00933 | SEA |
| Q9UJM8 | HAO1 | Hydroxyacid oxidase 1 | T63170 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q9UN88 | GABRQ | GABA(A) receptor theta | T15161 | SEA |
| P78329 | CYP4F2 | Cytochrome P450 4f | T82604 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T38200 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P48066 | SLC6A11 |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T63170 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | Q9UJM8 | HAO1 |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |